Ireland - English - HPRA (Health Products Regulatory Authority)

novo nordisk a/s - glucagon - powder and solvent for solution for injection - 1 milligram(s) - glycogenolytic hormones; glucagon

Singapore - English - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - glucagon (as hydrochloride) - injection, powder, for solution - 1mg/ml - glucagon (as hydrochloride) 1mg/ml

Israel - English - Ministry of Health

novo nordisk ltd., israel - glucagon as hydrochloride - powder and solvent for solution for injection - glucagon as hydrochloride 1 mg - glucagon - glucagon - treatment of severe hypoglycaemia reactions which may occur in the management of insulin treated persons with diabetes.

Malta - English - Medicines Authority

novonordisk a/s novo alle, dk – 2880 bagsvaerd, denmark - glucagon - powder and solvent for solution for injection - glucagon - pancreatic hormones

Malta - English - Medicines Authority

novonordisk a/s novo alle, dk – 2880 bagsvaerd, denmark - glucagon - powder and solvent for solution for injection - glucagon - pancreatic hormones

Canada - English - Health Canada

novo nordisk canada inc - glucagon (recombinant dna origin) (glucagon hydrochloride) - kit - 1mg - glucagon (recombinant dna origin) (glucagon hydrochloride) 1mg - glycogenolytic agents

Canada - English - Health Canada

novo nordisk canada inc - glucagon (recombinant dna origin) (glucagon hydrochloride) - kit - 1mg - glucagon (recombinant dna origin) (glucagon hydrochloride) 1mg - glycogenolytic agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novo nordisk ltd - glucagon hydrochloride - powder and solvent for solution for injection - 1mg

European Union - English - EMA (European Medicines Agency)

eli lilly nederland b.v. - glucagon - diabetes mellitus - pancreatic hormones, glycogenolytic hormones - baqsimi is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 4 years and over with diabetes mellitus.

European Union - English - EMA (European Medicines Agency)

tetris pharma b.v - glucagon - diabetes mellitus - pancreatic hormones, glycogenolytic hormones - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.